These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9166304)

  • 61. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection.
    Moraes ME; Cunha GH; Bezerra MM; Fechine FV; Pontes AV; Andrade WS; Frota Bezerra FA; Moraes MO; Cavalcanti PP
    Arch Gynecol Obstet; 2012 Jul; 286(1):125-30. PubMed ID: 22350328
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interventions for treating trichomoniasis in women.
    Forna F; Gülmezoglu AM
    Cochrane Database Syst Rev; 2000; (3):CD000218. PubMed ID: 10908466
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Tinidazol (CP, 12-574) in the treatment of vaginal trichomoniasis].
    Lam Salinas P
    Rev Clin Esp; 1971 Oct; 123(2):173-6. PubMed ID: 5139384
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of trichomonal vaginitis with a single oral dose of metronidazole.
    Woodcock KR
    Br J Vener Dis; 1972 Feb; 48(1):65-8. PubMed ID: 4552590
    [No Abstract]   [Full Text] [Related]  

  • 66. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis.
    Dombrowski MP; Sokol RJ; Brown WJ; Bronsteen RA
    Obstet Gynecol; 1987 Mar; 69(3 Pt 2):524-5. PubMed ID: 3492696
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Persistent vaginitis caused by metronidazole-resistant trichomonas.
    Grossman JH; Galask RP
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):521-2. PubMed ID: 2381638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonoxynol 9 as an additive therapy in metronidazole-resistant cases of vaginal trichomoniasis.
    El Bassiouni SO; Riad RM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):551-62. PubMed ID: 16083067
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of two plant extracts against vaginal trichomoniasis.
    El-Sherbini GT; El Gozamy BR; Abdel-Hady NM; Morsy TA
    J Egypt Soc Parasitol; 2009 Apr; 39(1):47-58. PubMed ID: 19530609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.
    Tayal S
    Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interventions for treating trichomoniasis in women.
    Forna F; Gülmezoglu AM
    Cochrane Database Syst Rev; 2003; (2):CD000218. PubMed ID: 12804391
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis.
    Peixoto F; Camargos A; Duarte G; Linhares I; Bahamondes L; Petracco A
    Int J Gynaecol Obstet; 2008 Sep; 102(3):287-92. PubMed ID: 18603245
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nimorazole compared with metronidazole in the treatment of vaginal trichomoniasis.
    Tinkler AE
    Practitioner; 1974 Jan; 212(267):115-9. PubMed ID: 4591199
    [No Abstract]   [Full Text] [Related]  

  • 75. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Flunidazole--a new drug for systemic treatment of urogenital trichomoniasis.
    Pereyra AJ; Nelson RM; Ludders DJ
    Am J Obstet Gynecol; 1972 Apr; 112(7):963-6. PubMed ID: 4557646
    [No Abstract]   [Full Text] [Related]  

  • 78. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis].
    Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R
    Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of trichomoniasis with metronidazole rectal suppositories.
    Panja SK
    Br J Vener Dis; 1982 Aug; 58(4):257-8. PubMed ID: 7104657
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis].
    Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E
    Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.